Advanced search
Publication Cover
Clinical Toxicology Volume 50, 2012 - Issue 1
Submit an article Journal homepage
609
Views
26
CrossRef citations to date
0
Altmetric
Critical Care

Severe paramethoxymethamphetamine (PMMA) and paramethoxyamphetamine (PMA) outbreak in Israel

Yael LurieRambam Health Care Campus, Israel Poison Information Center, Haifa, Israel
,
Asher GopherSheba Medical Center, Institute of Clinical Pharmacology and Toxicology, Tel Hashomer, Israel
,
Ophir LavonRambam Health Care Campus, Israel Poison Information Center, Haifa, Israel
,
Shlomo AlmogSheba Medical Center, Institute of Clinical Pharmacology and Toxicology, Tel Hashomer, Israel
,
Liron SulimaniSheba Medical Center, Institute of Clinical Pharmacology and Toxicology, Tel Hashomer, Israel
&
Yedidia BenturRambam Health Care Campus, Israel Poison Information Center, Haifa, Israel;Technion-Israel Institute of Technology, The Rappaport Faculty of Medicine, Haifa, IsraelCorrespondence[email protected]
Pages 39-43 | Received 26 Jul 2011, Accepted 19 Oct 2011, Published online: 13 Dec 2011

References

  • Baselt RC. Disposition of toxic drugs and chemicals in man. Foster City, CA: Biomedical Publications; 2002.
  • Lin DL, Liu HC, Yin HL. Recent paramethoxymethamphetamine (PMMA) deaths in Taiwan. J Anal Toxicol 2007; 31:109–113.
  • Johansen SS, Hansen AC, Muller IB, Lundemose JB, Franzmann MB. Three fatal cases of PMA and PMMA poisoning in Denmark. J Anal Toxicol 2003; 27:253–256.
  • Becker J, Neis P, Rohrich J, Zorntlein S. A fatal paramethoxymethamphetamine intoxication. Leg Med (Tokyo) 2003; 5 Suppl 1:S138–141.
  • Cimbura G. PMA deaths in Ontario. Can Med Assoc J 1974; 110:1263–1267.
  • Kraner JC, McCoy DJ, Evans MA, Evans LE, Sweeney BJ. Fatalities caused by the MDMA-related drug paramethoxyamphetamine (PMA). J Anal Toxicol 2001; 25:645–648.
  • Martin TL. Three cases of fatal paramethoxyamphetamine overdose. J Anal Toxicol 2001; 25:649–651.
  • Byard RW, Rodgers NG, James RA, Kostakis C, Camilleri AM. Death and paramethoxyamphetamine – an evolving problem. Med J Aust 2002; 176:496.
  • Felgate HE, Felgate PD, James RA, Sims DN, Vozzo DC. Recent paramethoxyamphetamine deaths. J Anal Toxicol 1998; 22:169–172.
  • Lamberth PG, Ding GK, Nurmi LA. Fatal paramethoxy-amphetamine (PMA) poisoning in the Australian Capital Territory. Med J Aust 2008; 188:426.
  • Voorspoels S, Coucke V, Covaci A, Maervoet J, Schepens P, DeMeyere C, Jacobs W. Resurgence of a lethal drug: paramethoxyamphetamine deaths in Belgium. J Toxicol Clin Toxicol 2002; 40: 203–204.
  • Daws LC, Irvine RJ, Callaghan PD, Toop NP, White JM, Bochner F. Differential behavioural and neurochemical effects of para-methoxyamphetamine and 3,4-methylenedioxymethamphetamine in the rat. Prog Neuropsychopharmacol Biol Psychiatry 2000; 24:955–977.
  • Green AL, El Hait MA. p-Methoxyamphetamine, a potent reversible inhibitor of type-A monoamine oxidase in vitro and in vivo. J Pharm Pharmacol 1980; 32:262–266.
  • Kaminskas LM, Irvine RJ, Callaghan PD, White JM, Kirkbride P. The contribution of the metabolite p-hydroxyamphetamine to the central actions of p-methoxyamphetamine. Psychopharmacology (Berl) 2002; 160:155–160.
  • Staack RF, Maurer HH. Metabolism of designer drugs of abuse. Curr Drug Metab 2005; 6:259–274.
  • Kitchen I, Tremblay J, Andre J, Dring LG, Idle JR, Smith RL, Williams RT. Interindividual and interspecies variation in the metabolism of the hallucinogen 4-methoxyamphetamine. Xenobiotica 1979; 9:397–404.
  • Caldicott DG, Edwards NA, Kruys A, Kirkbride KP, Sims DN, Byard RW, . Dancing with “death”: p-methoxyamphetamine overdose and its acute management. J Toxicol Clin Toxicol 2003; 41:143–154.
  • Lora-Tamayo C, Tena T, Rodriguez A. Amphetamine derivative related deaths. Forensic Sci Int 1997; 85:149–157.
  • Ling LH, Marchant C, Buckley NA, Prior M, Irvine RJ. Poisoning with the recreational drug paramethoxyamphetamine (“death”). Med J Aust 2001; 174:453–455.
  • Moffat AC. Clarke's analysis of drugs and poisons in pharmaceuticals, body fluids and postmortem material. London, Chicago: Parmaceutical Press; 2003.
  • Glennon RA, Young R, Dukat M, Cheng Y. Initial characterization of PMMA as a discriminative stimulus. Pharmacol Biochem Behav 1997; 57:151–158.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.